Literature DB >> 18695659

Sirolimus in unmanipulated haploidentical cell transplantation.

L von Reyn Cream, W C Ehmann, W B Rybka, D F Claxton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18695659     DOI： 10.1038/bmt.2008.242

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

Review 1.  Modern approaches to HLA-haploidentical blood or marrow transplantation.

Authors:  Christopher G Kanakry; Ephraim J Fuchs; Leo Luznik
Journal:  Nat Rev Clin Oncol       Date:  2015-08-25       Impact factor: 66.675

2.  Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

Authors:  J Peccatori; A Forcina; D Clerici; R Crocchiolo; L Vago; M T L Stanghellini; M Noviello; C Messina; A Crotta; A Assanelli; S Marktel; S Olek; S Mastaglio; F Giglio; L Crucitti; A Lorusso; E Guggiari; F Lunghi; M Carrabba; M Tassara; M Battaglia; A Ferraro; M R Carbone; G Oliveira; M G Roncarolo; S Rossini; M Bernardi; C Corti; M Marcatti; F Patriarca; M Zecca; F Locatelli; C Bordignon; K Fleischhauer; A Bondanza; C Bonini; F Ciceri
Journal:  Leukemia       Date:  2014-06-04       Impact factor: 11.528

3.  Sirolimus augments hematopoietic stem and progenitor cell regeneration following hematopoietic insults.

Authors:  Zenghua Lin; Maile K Hollinger; Zhijie Wu; Wanling Sun; Kaylind Batey; Jisoo Kim; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Stem Cells       Date:  2020-12-12       Impact factor: 6.277
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.